52 results
Page 2 of 3
8-K
EX-99.1
232tth
13 Nov 19
Other Events
7:16am
8-K
EX-99.1
zbsjh2k6 zx
8 Nov 19
Recro Pharma Reports Third Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
uhwlrlf70lmchk
31 Oct 19
Other Events
10:10am
8-K
EX-99.1
kc0lqcl
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.1
73mpk78
10 May 19
Recro Pharma Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
6vk h5eku0s5loz2
5 Apr 19
Cost Associated with Exit or Disposal Activities
4:01pm
8-K
EX-99.1
26mkxif t5hm
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-10.1
f6wwee7ejj 53ngz0q
4 Mar 19
Entry into a Material Definitive Agreement
7:05am
8-K
EX-99.1
06hczdx
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-10.1
qmbg2t8h
4 Jan 19
Entry into a Material Definitive Agreement
4:23pm
8-K
EX-99.1
s96fm
10 Dec 18
Other Events
2:07pm
8-K
EX-99.1
xag0qv
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.1
6mx2 qkaj9
9 Oct 18
Recro Pharma Announces PDUFA Date for IV Meloxicam
6:07am
8-K
EX-99.1
6zhwl42dlcn93qv
1 Oct 18
Recro Announces Expansion of CDMO Service Capabilities
12:00am
8-K
EX-99.1
yi9oo
7 Aug 18
Recro Pharma Reports Second Quarter 2018 Financial Results
7:05am
8-K
EX-99.1
jm154
9 May 18
Recro Pharma Reports First Quarter 2018 Financial Results
7:01am
8-K
EX-99.1
2w4o00w fexbe
7 May 18
Other Events
9:41am
8-K
EX-99.1
aiusk
30 Apr 18
Other Events
7:15am